Quarterly report pursuant to Section 13 or 15(d)

Schedule of receivables with imputed interest (Details)

v3.23.3
Schedule of receivables with imputed interest (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Investment In Account Receivable    
Face value [1] $ 285,700 $ 403,600
Unamortized discount (61,200) (88,291)
Net balance 224,500 315,309
Current portion
Long term portion $ 224,500 $ 315,309
[1] On January 10, 2023, the Company received the 2022 annual installment payment of $117,000. The Company applied the $117,000 to the face value of its investment in account receivable. Additionally, the Company reduced the face value of its investment in account receivable by an additional $100 per month for the nine months ended September 30, 2023.